| http://www.w3.org/ns/prov#value | - While losing a large chunk of revenue due to the patent cliff and while cutting research and sales headcounts at home and in other mature markets, big multinational pharmaceutical companies are looking for growth drivers elsewhere around the globe, particularly in emerging markets such as the BRICS (Brazil, Russia, India, China, and South Africa).
|
